{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:58Z","timestamp":1786985098118,"version":"build-2736575974"},"reference-count":78,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bprclinrheum.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.berh.2016.10.007","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T11:03:05Z","timestamp":1478689385000},"page":"802-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis"],"prefix":"10.1016","volume":"30","author":[{"given":"Philip Ian","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saaeha","family":"Rauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2016.10.007_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2016.10.007_bib2","first-page":"153","article-title":"Scleritis: challenges in immunopathogenesis and treatment","volume":"16","author":"Wakefield","year":"2013","journal-title":"Discov Med"},{"key":"10.1016\/j.berh.2016.10.007_bib3","first-page":"121","article-title":"Retinal vasculitis in rheumatoid arthritis: an angiographic study","volume":"8","author":"Giordano","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2016.10.007_bib4","first-page":"1098","article-title":"Secondary Sj\u00f6gren's syndrome in rheumatoid arthritis","volume":"14","author":"Andonopoulos","year":"1987","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.007_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye WorkShop","volume":"5","author":"No_authors_listed","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.berh.2016.10.007_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtos.2012.02.001","article-title":"Report of the TFOS\/ARVO Symposium on global treatments for dry eye disease: an unmet need","volume":"10","author":"Sullivan","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.berh.2016.10.007_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jtos.2015.11.002","article-title":"Economic and humanistic burden of dry eye disease in Europe, North America, and Asia: a systematic literature review","volume":"14","author":"McDonald","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.berh.2016.10.007_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1542-0124(12)70043-5","article-title":"Utility assessment to measure the impact of dry eye disease","volume":"4","author":"Buchholz","year":"2006","journal-title":"Ocul Surf"},{"key":"10.1016\/j.berh.2016.10.007_bib9","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","article-title":"Utility assessment among patients with dry eye disease","volume":"110","author":"Schiffman","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajo.2014.11.028","article-title":"The association between dry eye disease and depression and anxiety in a large population-based study","volume":"159","author":"van der Vaart","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/eye.2016.186","article-title":"Depression and anxiety in dry eye disease: a systematic review and meta-analysis","author":"Wan","year":"2016","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.berh.2016.10.007_bib12","first-page":"163","article-title":"Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international dry eye WorkShop","volume":"2007","author":"No authors listed","year":"2007","journal-title":"Ocul Surf"},{"key":"10.1016\/j.berh.2016.10.007_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1542-0124(12)70290-2","article-title":"Corneal pain without stain: is it real?","volume":"7","author":"Rosenthal","year":"2009","journal-title":"Ocul Surf"},{"key":"10.1016\/j.berh.2016.10.007_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","article-title":"A\u00a0simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren's syndrome International Registry","volume":"149","author":"Whitcher","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib15","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2016.10.007_bib16","first-page":"948","article-title":"Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells","volume":"42","author":"Geerling","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2016.10.007_bib17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1167\/iovs.06-0848","article-title":"Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing","volume":"48","author":"Garrett","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.berh.2016.10.007_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jtos.2015.12.004","article-title":"Effects of punctal occlusion on clinical signs and symptoms and on tear cytokine levels in patients with dry eye","volume":"14","author":"Tong","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.berh.2016.10.007_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/bjo.2005.078865","article-title":"Conjunctival epithelium improvement after systemic pilocarpine in patients with Sj\u00f6gren's syndrome","volume":"90","author":"Aragona","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sjogren's syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/bjo.83.8.941","article-title":"Incidence of corneal melting in association with systemic disease in the Yorkshire Region, 1995\u20137","volume":"83","author":"McKibbin","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib22","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrrheum.2014.85","article-title":"The eye: a window of opportunity in rheumatoid arthritis?","volume":"10","author":"Tong","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2016.10.007_bib23","first-page":"393","article-title":"Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies","volume":"9","author":"Vignesh","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib24","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/ICO.0000000000000008","article-title":"Peripheral ulcerative keratitis and corneal melt: a 10-year single center review with historical comparison","volume":"33","author":"Knox Cartwright","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.berh.2016.10.007_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/112067210601600602","article-title":"Rheumatoid keratolysis: a series of 40 eyes","volume":"16","author":"Malik","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib27","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/bjophthalmol-2012-302130","article-title":"Ten-year experience of pulsed intravenous cyclophosphamide and methylprednisolone protocol (PICM protocol) in severe ocular inflammatory disease","volume":"97","author":"Khan","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/09273948.2016.1136190","volume":"24","author":"Cunningham","year":"2016","journal-title":"Scleritis Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2016.10.007_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib30","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ophtha.2007.03.018","article-title":"Rheumatic disease and scleritis","volume":"114","author":"Galor","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.rdc.2007.08.002","article-title":"Scleritis and peripheral ulcerative keratitis","volume":"33","author":"Galor","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.berh.2016.10.007_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09273948.2015.1005240","article-title":"Posterior scleritis: analysis of epidemiology, clinical factors, and risk of recurrence in a cohort of 114 patients","volume":"24","author":"Lavric","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2016.10.007_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/09273948.2015.1032308","article-title":"Flurbiprofen: a nonselective cyclooxygenase (COX) inhibitor for treatment of noninfectious, non-necrotizing anterior scleritis","volume":"24","author":"Agrawal","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2016.10.007_bib35","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ophtha.2011.02.043","article-title":"Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis","volume":"118","author":"Sohn","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib36","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0161-6420(03)00570-0","article-title":"Mycophenolate mofetil for the treatment of scleritis","volume":"110","author":"Sen","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib37","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3129\/i09-061","article-title":"Infliximab for the treatment of active scleritis","volume":"44","author":"Sen","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib38","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.ophtha.2014.04.044","article-title":"Rituximab therapy for refractory scleritis: results of a phase I\/II dose-ranging, randomized, clinical trial","volume":"121","author":"Suhler","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preteyeres.2013.02.004","article-title":"Scleritis: immunopathogenesis and molecular basis for therapy","volume":"35","author":"Wakefield","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.berh.2016.10.007_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1442-9071.1991.tb00663.x","article-title":"Prediction of response to treatment in patients with scleritis using a standardized scoring system","volume":"19","author":"McCluskey","year":"1991","journal-title":"Aust N. Z J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib41","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ophtha.2010.08.027","article-title":"A\u00a0standardized grading system for scleritis","volume":"118","author":"Sen","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0161-6420(99)90157-4","article-title":"Severity of episcleritis and systemic disease association","volume":"106","author":"Akpek","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.survophthal.2016.06.002","article-title":"Treatment and management of scleral disorders","volume":"61","author":"Diaz","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ophtha.2003.07.011","article-title":"Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases","volume":"111","author":"Monnet","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.berh.2016.10.007_bib45","first-page":"1","article-title":"Clinical spectrum of HLA-B27-associated ocular inflammation","author":"Pathanapitoon","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2016.10.007_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-9394(14)74218-7","article-title":"Clinical features of acute anterior uveitis","volume":"103","author":"Rothova","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib47","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/09273948.2016.1175642","article-title":"Review for disease of the year: epidemiology of HLA-B27 associated ocular disorders","volume":"24","author":"Kopplin","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2016.10.007_bib48","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","author":"de Smet","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.berh.2016.10.007_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature (SUN) working group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273940801899822","article-title":"International uveitis study group. International uveitis study group (IUSG): clinical classification of uveitis","volume":"16","author":"Deschenes","year":"2008","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.berh.2016.10.007_bib51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2016.02.024","article-title":"Potential predictors of poor visual outcome in Human Leukocyte Antigen-B27-associated uveitis","volume":"165","author":"Verhagen","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","article-title":"Acute anterior uveitis and HLA-B27","volume":"50","author":"Chang","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jcrs.2013.09.013","article-title":"Long-term biocompatibility and visual outcomes of a hydrophilic acrylic intraocular lens in patients with uveitis","volume":"40","author":"Tomlins","year":"2014","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.berh.2016.10.007_bib54","first-page":"1277","article-title":"Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period","volume":"30","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.10.007_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2000.84","article-title":"Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis","volume":"14","author":"Benitez-Del-Castillo","year":"2000","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.berh.2016.10.007_bib56","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/eye.2008.198","article-title":"Methotrexate: an option for preventing the recurrence of acute anterior uveitis","volume":"23","author":"Mu\u00f1oz-Fern\u00e1ndez","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.berh.2016.10.007_bib57","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/rheumatology\/ken091","article-title":"Do TNF-blockers reduce or induce uveitis?","volume":"47","author":"Cobo-Ib\u00e1\u00f1ez","year":"2008","journal-title":"Rheumatol Oxf"},{"key":"10.1016\/j.berh.2016.10.007_bib58","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2006.052092","article-title":"Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study","volume":"65","author":"Guignard","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.007_bib59","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.092585","article-title":"Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.007_bib60","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","article-title":"Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept","volume":"52","author":"Braun","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.007_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12891-015-0489-2","article-title":"Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis","volume":"16","author":"Wu","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.berh.2016.10.007_bib62","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1185\/03007995.2014.969368","article-title":"Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database","volume":"30","author":"Wendling","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.berh.2016.10.007_bib63","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2016.10.007_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1185\/03007995.2014.993024","article-title":"BIOGEAS Study Group. Etanercept and uveitis: friends or foes?","volume":"31","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.berh.2016.10.007_bib65","doi-asserted-by":"crossref","first-page":"471319","DOI":"10.1155\/2014\/471319","article-title":"Inefficacy or paradoxical effect? Uveitis in ankylosing spondylitis treated with etanercept","volume":"2014","author":"Raffeiner","year":"2014","journal-title":"Case Rep Med"},{"key":"10.1016\/j.berh.2016.10.007_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajo.2016.07.016","article-title":"Anti-TNF\u03b1 treatment for HLA-B27 positive ankylosing spondylitis-related uveitis","volume":"170","author":"Kim","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib67","first-page":"1054","article-title":"Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents","volume":"15","author":"Gao","year":"2012","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.berh.2016.10.007_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00417-014-2772-6","article-title":"Acute anterior uveitis and undiagnosed spondyloarthritis: usefulness of Berlin criteria","volume":"253","author":"Wach","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11926-015-0536-x","article-title":"Acute anterior uveitis and spondyloarthritis: more than meets the eye","volume":"17","author":"Khan","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2016.10.007_bib70","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1136\/annrheumdis-2014-205358","article-title":"A\u00a0novel evidence-based detection of undiagnosed spondyloarthritis in patients\u00a0presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool)","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.007_bib71","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaad.2010.10.032","article-title":"Ocular psoriasis","volume":"65","author":"Rehal","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.berh.2016.10.007_bib72","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/ard.35.4.354","article-title":"Eye inflammation in psoriatic arthritis","volume":"35","author":"Lambert","year":"1976","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.007_bib73","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10067-015-2960-8","article-title":"Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease","volume":"34","author":"Rosenbaum","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.berh.2016.10.007_bib74","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamadermatol.2015.1986","article-title":"Association of psoriatic disease with uveitis: a Danish nationwide cohort study","volume":"151","author":"Egeberg","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.berh.2016.10.007_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3899\/jrheum.150630","article-title":"Uveitis in spondyloarthritis: an overview","volume":"93","author":"Cantini","year":"2015","journal-title":"J\u00a0Rheumatol Suppl"},{"key":"10.1016\/j.berh.2016.10.007_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08820538.2016.1170161","article-title":"Psoriasis and psoriatic arthritis-related uveitis: different ophthalmological manifestations\u00a0and ocular inflammation features","author":"Abbouda","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.berh.2016.10.007_bib77","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/ard.59.1.67","article-title":"Characterisation of uveitis in patients with psoriatic arthritis","volume":"59","author":"Paiva","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2016.10.007_bib78","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clindermatol.2014.10.017","article-title":"Phototherapy-related ophthalmologic disorders","volume":"33","author":"DePry","year":"2015","journal-title":"Clin Dermatol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T08:04:48Z","timestamp":1568534688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694216300808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1521694216300808"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2016.10.007","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The eye and inflammatory rheumatic diseases: The eye and rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2016.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}